This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

program

Sunday, May 26, 2019

7:00 - 8:00 AM
CASL Special Interest Group Meetings

  • HBV
  • CPHRG
  • Portal Hypertension & Complications of Cirrhosis

7:30 - 9:30 AM
CAHN Annual General Meeting (Members Only) 

8:00 - 8:50 AM
General Hepatitis Oral Abstract Presentations

  • Vitamin E is an Effective Treatment for NASH in People Living with HIV: The CTN-PT 024 Trial
    Giada Sebastiani, McGill University
  • Why Women Develop Less Hepatocellular Carcinoma: The Centrality of ESR1 and the Estrogen Effect
    Mamatha Bhat, University Health Network
  • CD8+ T-cell Dysfunction in a Murine Model of Liver Fibrosis
    Angela Crawley, University of Ottawa
  • Implementation of a Primary Care Shear-Wave Elastography (SWE)-Based Pathway to Identify Non-Alcoholic Fatty Liver Disease (NAFLD) Patients with Advanced Fibrosis in a Large North American Urban Population
    Abdel Aziz Shaheen, University of Calgary
  • Acyl CoA Thioesterase 1 Promotes Transition from Steatosis to Non-alcoholic Steatohepatitis
    Elisa Pasini, University Health Network

9:00 - 10:15 AM
Concurrent Session

  • Immune Control/Dysfunction & Liver Disease

    • Visualizing the Immune Response in Healthy & Fatty Liver in Live Mice
      Craig Jenne, University of Calgary
    • Mechanisms Linking the Hemostatic System to Pro-Repair Macrophage Activation in Acute Liver Injury
      Jim Luyendyke, Michigan State University
    • Novel HBV Tests & Diagnostics
      Carla Osiowy, Public Health Agency of Canada
    • Progression Towards a Functional Cure for Hepatitis B
      Norah Terrault, USC Keck School of Medicine
  • End Stage Liver Disease and Liver Transplantation 

    • Referral & Optimizing Pre-Transplant in NASH/NAFLD
      Giada Sebastini, McGill University
    • Use of HCV + Organ in Transplant Patients - Kidney and Liver
      Jordan Feld, University Health Network
    • Sex & Gender Differences in Listing & Allocation for Liver Transplant
      Mamatha Bhat, University Health Network

10:15 - 11:15 AM
Break, Posters & Exhibits

10:15 - 11:15 AM
CASL Special Interest Group Meeting

  • Autoimmune Liver Diseases (CaNAL)

11:15 - 12:45 PM
Gold Medal Lecture & CASL Award Ceremony

11:15 - 12:00 PM
Updates on the Treatments of Ascites and Hepatorenal Syndrome Florence Wong, University of Toronto

12:00 - 12:45 PM
CASL Awards and Conference Closing

12:45 PM
CASL Awards and Conference Closing